MADRIGAL PHARMACEUTICALS, INC. 4
4 · MADRIGAL PHARMACEUTICALS, INC. · Filed Mar 6, 2017
Insider Transaction Report
Form 4
Schneebaum Marc R
SVP and CFO
Transactions
- Award
Stock Option (Right to Buy)
2017-03-02+27,300→ 27,300 totalExercise: $15.80Exp: 2027-03-02→ Common Stock (27,300 underlying)
Footnotes (1)
- [F1]The option vests as to 25% of the shares on the first anniversary of the date of grant (March 2, 2018) and, thereafter, 6.25% of the shares shall vest on the last day of each successive three month period, provided the Reporting Person continues to serve as an officer of the Issuer on each such date.